Cat. No：GM-87991MAB
Product：Anti-TSPAN8 hIgG1 Reference Antibody (Ts29.2)
Cat. No：GM-87991MAB
Product：Anti-TSPAN8 hIgG1 Reference Antibody (Ts29.2)
GM-87991MAB-1mg / 1 mg |
GM-87991MAB-5mg / 5 mg |
GM-87991MAB-25mg / 5 mg * 5 vials |
GM-87991MAB-50mg / 50 mg |
GM-87991MAB-100mg / 50 mg * 2 vials |
Expression System | CHO |
Aggregation | < 5% as determined by SEC-HPLC |
Purity | > 95% as determined by SDS-PAGE |
Endotoxin | < 1 EU/mg, determined by LAL gel clotting assay |
Sterility | 0.2 μm Filtered |
Target | TSPAN8 |
Clone | Ts29.2 |
Alternative Names | CO-029, TM4SF3 |
Source/Isotype | Monoclonal Human IgG1(KDEL), Kappa |
Application | / |
Description | TSPAN8 is an important regulatory factor in tumor development and metastasis, and its functional research holds significant value in the fields of tumor biology and therapy. As a powerful tool targeting TSPAN8, the Ts29.2 antibody can be developed as a targeted carrier to precisely deliver toxic drugs or other therapeutic molecules to tumor cells with high TSPAN8 expression, thereby enhancing treatment precision and reducing side effects. |
Formulation | phosphate-buffered solution, pH 7.2-7.4. |
Cat. No：GM-87991MAB
Product：Anti-TSPAN8 hIgG1 Reference Antibody (Ts29.2)
GM-87991MAB-1mg / 1 mg |
GM-87991MAB-5mg / 5 mg |
GM-87991MAB-25mg / 5 mg * 5 vials |
GM-87991MAB-50mg / 50 mg |
GM-87991MAB-100mg / 50 mg * 2 vials |
Expression System | CHO |
Aggregation | < 5% as determined by SEC-HPLC |
Purity | > 95% as determined by SDS-PAGE |
Endotoxin | < 1 EU/mg, determined by LAL gel clotting assay |
Sterility | 0.2 μm Filtered |
Target | TSPAN8 |
Clone | Ts29.2 |
Alternative Names | CO-029, TM4SF3 |
Source/Isotype | Monoclonal Human IgG1(KDEL), Kappa |
Application | / |
Description | TSPAN8 is an important regulatory factor in tumor development and metastasis, and its functional research holds significant value in the fields of tumor biology and therapy. As a powerful tool targeting TSPAN8, the Ts29.2 antibody can be developed as a targeted carrier to precisely deliver toxic drugs or other therapeutic molecules to tumor cells with high TSPAN8 expression, thereby enhancing treatment precision and reducing side effects. |
Formulation | phosphate-buffered solution, pH 7.2-7.4. |
